Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Pathology
Volume 2017, Article ID 6749801, 6 pages
https://doi.org/10.1155/2017/6749801
Case Report

Mantle Cell Lymphoma in the Thyroid: A Rare Presentation

1Division of Endocrinology, University of Massachusetts Medical School, 55 Lake Avenue N., Worcester, MA 01655, USA
2Section of Endocrinology, MedStar Washington Hospital Center, 110 Irving St NW, Suite 2A-72, Washington, DC 20010, USA
3Department of Pathology, University of Massachusetts Medical School, Biotech 3, 1 Innovation Drive, Worcester, MA, USA
4Division of Hematology and Oncology, University of Massachusetts Medical School, 55 Lake Avenue N., Worcester, MA 01655, USA

Correspondence should be addressed to Uzma Mohammad Siddiqui; gro.lairomemssamu@iuqiddis.amzu

Received 4 August 2017; Revised 7 November 2017; Accepted 4 December 2017; Published 25 December 2017

Academic Editor: Piero Tosi

Copyright © 2017 Uzma Mohammad Siddiqui et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Sharma, S. Jasim, C. C. Reading et al., “Clinical presentation and diagnostic challenges of thyroid lymphoma: a cohort study,” Thyroid, vol. 26, no. 8, pp. 1061–1067, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Goy, “Mantle cell lymphoma: is it time for a new treatment paradigm?” Hematology/Oncology Clinics of North America, vol. 30, no. 6, pp. 1345–1370, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. L. H. Argatoff, J. M. Connors, R. J. Klasa, D. E. Horsman, and R. D. Gascoyne, “Mantle cell lymphoma: a clinicopathologic study of 80 cases,” Blood, vol. 89, no. 6, pp. 2067–2078, 1997. View at Google Scholar · View at Scopus
  4. J. E. Romaguera, L. J. Medeiros, and F. B. Hagemeister, “Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma,” Cancer, vol. 97, no. 3, pp. 586–591, 2003. View at Google Scholar · View at Scopus
  5. A. Graff-Baker, S. A. Roman, D. C. Thomas, R. Udelsman, and J. A. Sosa, “Prognosis of primary thyroid lymphoma: demographic, clinical, and pathologic predictors of survival in 1,408 cases,” Surgery, vol. 146, no. 6, pp. 1105–1115, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. S. H. Swerdlow, W.-I. Yang, L. R. Zukerberg, N. L. Harris, A. Arnold, and M. E. Williams, “Expression of cyclin D1 protein in centrocytic/mantle cell lymphomas with and without rearrangement of the BCL1/Cyclin D1 gene,” Human Pathology, vol. 26, no. 9, pp. 999–1004, 1995. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Rimokh, F. Berger, G. Delsol et al., “Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas,” Blood, vol. 83, no. 7, pp. 1871–1875, 1994. View at Google Scholar · View at Scopus
  8. A. Abrahamsson, A. Albertsson-Lindblad, P. N. Brown et al., “Real world data on primary treatment for mantle cell lymphoma: A Nordic Lymphoma Group observational study,” Blood, vol. 124, no. 8, pp. 1288–1295, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. C. V. Hojilla, A. Rajab, K. J. Craddock, L. E. Rotstein, and G. da Cunha Santos, “Mantle cell lymphoma involving the thyroid: a case report,” Cytopathology, vol. 27, no. 4, pp. 289–292, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Guastafierro, U. Falcone, M. Celentano et al., “Primary mantle cell lymphoma of the thyroid,” Leukemia Research, vol. 34, no. 4, pp. 548–550, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. J. P. Logue, R. J. Hale, A. L. Stewart, M. B. Duthie, and S. S. Banerjee, “Primary malignant lymphoma of the thyroid: A clinicopathological analysis,” International Journal of Radiation Oncology, Biology, Physics, vol. 22, no. 5, pp. 929–933, 1992. View at Publisher · View at Google Scholar · View at Scopus
  12. F. P. Ruggiero, E. Frauenhoffer, and B. C. Stack Jr., “Thyroid lymphoma: a single institution’s experience,” Otolaryngology—Head and Neck Surgery, vol. 133, no. 6, pp. 888–896, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Kishanprasad, P. Hegde, R. Chandrika, and K. Jayaprakash, “Hashimotos thyroiditis with coexistent papillary carcinoma and non-hodgkin lymphoma-thyroid,” Annals of Medical and Health Sciences Research, vol. 4, no. 2, pp. 268–270, 2014. View at Google Scholar
  14. M. O. Khalil, L. M. Morton, and S. S. Devesa, “Incidence of marginal zone lymphoma in the United States, 2001–2009 with a focus on primary anatomic site,” British Journal of Haematology, vol. 165, no. 1, pp. 67–77, 2014. View at Publisher · View at Google Scholar
  15. R. I. Fisher, S. Dahlberg, B. N. Nathwani, P. M. Banks, T. P. Miller, and T. M. Grogan, “A clinical analysis of two indolent lymphoma entities: Mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): a Southwest oncology group study,” Blood, vol. 85, no. 4, pp. 1075–1082, 1995. View at Google Scholar · View at Scopus
  16. O. Determann, E. Hoster, G. Ott et al., “Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade Lymphoma Study Group,” Blood, vol. 111, no. 4, pp. 2385–2387, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. M. B. Møller, N. T. Pedersen, and B. E. Christensen, “Mantle cell lymphoma: Prognostic capacity of the Follicular Lymphoma International Prognostic Index,” British Journal of Haematology, vol. 133, no. 1, pp. 43–49, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Hoster, M. Dreyling, W. Klapper et al., “A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma,” Blood, vol. 111, no. 2, pp. 558–565, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Chen, J. Sanchez, and S. T. Rosen, “Clinical management updates in mantle cell lymphoma,” Oncology, vol. 30, no. 4, pp. 353–360, 2016. View at Google Scholar · View at Scopus
  20. B. D. Rosenbluth and J. Yahalom, “Highly effective local control and palliation of mantle cell lymphoma with involved-field radiation therapy (IFRT),” International Journal of Radiation Oncology, Biology, Physics, vol. 65, no. 4, pp. 1185–1191, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Martin, A. Chadburn, P. Christos et al., “Outcome of deferred initial therapy in mantle-cell lymphoma,” Journal of Clinical Oncology, vol. 27, no. 8, pp. 1209–1213, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Ruan and P. Martin, “Which patients with mantle cell lymphoma do not need aggressive therapy,” Current Heart Failure Reports, vol. 11, no. 3, pp. 234–240, 2016. View at Publisher · View at Google Scholar · View at Scopus